XML 21 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Consolidated Statements of Earnings - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Income Statement [Abstract]      
Net Sales $ 7,824.1 $ 7,683.9 $ 5,997.8
Cost of products sold, excluding intangible asset amortization 2,132.9 2,381.8 1,800.6
Intangible asset amortization 603.9 565.9 337.4
Research and development 367.4 365.6 268.8
Selling, general and administrative 2,973.9 2,932.9 2,284.2
Goodwill impairment 304.7    
Special items (Note 2) 633.1 611.8 839.5
Operating expenses 7,015.9 6,858.0 5,530.5
Operating Profit 808.2 825.9 467.3
Other expense, net (18.3) (71.3) (36.9)
Interest income 2.2 2.9 9.4
Interest expense (327.5) (357.9) (286.6)
Earnings before income taxes 464.6 399.6 153.2
(Benefit) provision for income taxes (1,348.8) 95.0 7.0
Net earnings 1,813.4 304.6 146.2
Less: Net loss attributable to noncontrolling interest (0.4) (1.3) (0.8)
Net Earnings of Zimmer Biomet Holdings, Inc. $ 1,813.8 $ 305.9 $ 147.0
Earnings Per Common Share - Basic $ 8.98 $ 1.53 $ 0.78
Earnings Per Common Share - Diluted $ 8.90 $ 1.51 $ 0.77
Weighted Average Common Shares Outstanding      
Basic 201.9 200.0 187.4
Diluted 203.7 202.4 189.8
Cash Dividends Declared Per Common Share $ 0.96 $ 0.96 $ 0.88